$0.5108
-0.0781[-13.27%]
Last update: 2:49PM Get Real Time Here
Renalytix
(NASDAQ:RNLX)Renalytix Stock (NASDAQ:RNLX), Analyst Ratings, Price Targets, Predictions
Renalytix PLC has a consensus price target of $13.38, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on June 30, 2023, June 12, 2023, and June 5, 2023. With an average price target of $5 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 878.95% upside for Renalytix PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
BTIG
Stifel
Berenberg
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Renalytix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/30/2023 | Buy Now | 878.95% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | Buy Now | 878.95% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 878.95% | HC Wainwright & Co. | Yi Chen | → $5 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | Buy Now | 585.27% | BTIG | Mark Massaro | $4 → $3.5 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 878.95% | HC Wainwright & Co. | Yi Chen | $8 → $5 | Maintains | Buy | Get Alert |
| 12/02/2022 | Buy Now | 1466.32% | HC Wainwright & Co. | Yi Chen | $10 → $8 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | 1857.91% | HC Wainwright & Co. | Yi Chen | $15 → $10 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 878.95% | BTIG | Mark Massaro | $15 → $5 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 1270.53% | Stifel | Daniel Arias | $17 → $7 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | 2836.86% | HC Wainwright & Co. | Yi Chen | $30 → $15 | Maintains | Buy | Get Alert |
| 01/18/2022 | Buy Now | 5773.72% | HC Wainwright & Co. | Yi Chen | → $30 | Initiates | → Buy | Get Alert |
| 01/04/2022 | Buy Now | 4598.97% | BTIG | Mark Massaro | → $24 | Initiates | → Buy | Get Alert |
| 07/02/2021 | Buy Now | 7340.04% | Berenberg | Anita Dushyanth | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Renalytix (RNLX)?
The latest price target for Renalytix (NASDAQ: RNLX) was reported by HC Wainwright & Co. on June 30, 2023. The analyst firm set a price target for $5.00 expecting RNLX to rise to within 12 months (a possible 878.95% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Renalytix (RNLX)?
The latest analyst rating for Renalytix (NASDAQ: RNLX) was provided by HC Wainwright & Co., and Renalytix reiterated their buy rating.
When was the last upgrade for Renalytix (RNLX)?
There is no last upgrade for Renalytix.
When was the last downgrade for Renalytix (RNLX)?
There is no last downgrade for Renalytix.
When is the next analyst rating going to be posted or updated for Renalytix (RNLX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Renalytix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Renalytix was filed on June 30, 2023 so you should expect the next rating to be made available sometime around June 30, 2024.
Is the Analyst Rating Renalytix (RNLX) correct?
While ratings are subjective and will change, the latest Renalytix (RNLX) rating was a reiterated with a price target of $0.00 to $5.00. The current price Renalytix (RNLX) is trading at is $0.51, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.